Later results in Fig. 3 show expression of AURKA/B pathway genes is increased in NSCLC cells upon knockdown of p53, RBL2, or the essential DREAM component LIN37, confirming that these genes are repressed by RBL2-DREAM. The gene discussed is TP53; the disease is non-small cell lung carcinoma.